MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

metabolic works, page-12

  1. 2,082 Posts.
    lightbulb Created with Sketch. 1651
    you are very long this stock jevelent......certainly a credit to you, that never overly try to talk up the stock.

    However can I point out, they have a pain drug that has no real competition in a $5 billion market place. Phase 2 trials are underway now.

    IF and yes...I do mean IF, the drug got to market....MBP would derive at least 10% of revenues from all drug sales of ACV1. Lets say that only $1b of market share is achieved.

    That is still $100 m gross revenues (and a shareprice of $3) for MBP.

    Yes I know what you might say......even you jevalent (much less the other newbies)......that MBP has a long way to go before approvals and sales are generated.......but the whole point is the share price now is 16 cents.

    Look I can tell you.....IF they get throught (phase 2-resuts soon) we have a $120m company here.....which means a shareprice of 40 cents.

    Can I suggest .....you
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.